EDGAR Filing Documents for 0001104659-20-082791

Form 8-K - Current report:

SEC Accession No. 0001104659-20-082791

Filing Date

2020-07-10

Accepted

2020-07-10 17:17:53

Documents

Period of Report

2020-07-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2019067-12_8k.htm	8-K	40019
2	EXHIBIT 1.1	tm2019067d12_ex1-1.htm	EX-1.1	267920
3	EXHIBIT 10.1	tm2019067d12_ex10-1.htm	EX-10.1	84687
4	EXHIBIT 10.2	tm2019067d12_ex10-2.htm	EX-10.2	104882
5	EXHIBIT 10.3	tm2019067d12_ex10-3.htm	EX-10.3	37507
6	EXHIBIT 10.4	tm2019067d12_ex10-4.htm	EX-10.4	39579
7	EXHIBIT 10.5	tm2019067d12_ex10-5.htm	EX-10.5	44769
8	EXHIBIT 99.1	tm2019067d12_ex99-1.htm	EX-99.1	5346
9	EXHIBIT 99.2	tm2019067d12_ex99-2.htm	EX-99.2	5911
	Complete submission text file	0001104659-20-082791.txt		631925

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116

Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 617-778-2500

Therapeutics Acquisition Corp. (Filer) CIK: 0001811764 (see all company filings)